Notice of Correction to Key Dates for PAR-18-022 "Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional)"

Notice Number: NOT-CA-18-030

Key Dates
Release Date: December 22, 2017  

Related Announcements
PAR-18-022

Issued by
National Cancer Institute (NCI)

Purpose

This Notice corrects the Key Dates Section of Funding Opportunity (FOA) PAR-18-022 "Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional)".

The following Key Dates of the FOA have been corrected (in italics):

Part 1. Key Dates

Open Date (Earliest Submission Date):

Currently reads:
March 5, 2018

Should correctly read:
March 4, 2018

Application Due Date(s):

Currently reads:
April 4, 2019; November 1, 2019; April 4, 2020; November 1, 2020; April 4, 2021, November 1, 2021, by 5:00 PM local time of applicant organization. 

Should correctly read:
April 4, 2018; November 1, 2018; April 4, 2019, November 1, 2019, by 5:00 PM local time of applicant organization.

AIDS Application Due Date(s):

Currently reads:
May 7, 2019; January 7, 2020; May 7, 2020; January 7, 2021; May 7, 2021, January 7, 2022.

Should correctly read:
May 7, 2018; January 7, 2019; May 7, 2019, January 7, 2020.

Scientific Merit Review:

Currently reads:
June 2019; February 2020; June 2020; February 2021; June 2021; February 2022

Should correctly read:
June 2018; February 2019; June 2019; February 2020

Advisory Council Review:

Currently reads:
October 2019; May 2020; October 2020; May 2021; October 2021; May 2022

Should correctly read:
October 2018; May 2019; October 2019; May 2020

Earliest Start Date:

Currently reads:
October 2019; May 2020; October 2020; May 2021; October 2021; May 2022

Should correctly read:
October 2018; May 2019; October 2019; May 2020

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Mark Parascandola, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6871
Email: Mark.Parascandola@nih.gov